Chronic Toxicity Study
What is Chronic Toxicity?
Chronic toxicity studies are designed to assess the toxic effects resulting from prolonged and repeated exposure to a test substance, providing information on cumulative toxicity, target organ involvement, dose–response relationships, and the identification of a No-Observed-Adverse-Effect Level (NOAEL).
Observation period and assessment: Chronic toxicity studies involve repeated administration of a test substance for a prolonged period, typically ranging from 12 to 24 months, to evaluate long-term toxic effects and cumulative toxicity.
OECD Test Guidelines
OECD test guidelines governing subacute toxicity studies across oral, dermal, and inhalation routes of administration.
Principles
Repeated Long-Term Exposure: To evaluate cumulative toxic effects the test substance is administered daily at different dose levels for an extended period (typically about 12 months or longer).
Assessment of Chronic Toxicity and Carcinogenicity: Animals are continuously monitored for clinical signs of toxicity, target organ effects, and the development of neoplastic (tumor) lesions.
Comprehensive Pathological Evaluation: Animals that die during study and those surviving until study completion undergo necropsy and pathological examination to identify treatment-related adverse effects.
Objectives of Chronic toxicity study
Each chronic toxicity study is designed to achieve specific scientific and regulatory objectives.
To evaluate the long-term toxic effects of a test substance following repeated exposure over an extended period.
To identify target organs and cumulative toxicity that may result from prolonged administration of the test substance.
To determine the No-Observed-Adverse-Effect Level (NOAEL) and assess potential health risks associated with chronic exposure.
To assess dose–response relationships and provide data for risk assessment and safe exposure limits.
To detect delayed or irreversible adverse effects, including potential carcinogenic changes following long-term treatment.
Experimental Animals
Standardized rodent models are selected based on regulatory acceptability and biological relevance.
Wistar Rat (Rat Model)
Sprague Dawley Rat (Rat Model)
Swiss Albino Mice (Mouse Model)
BALB/C Mice (Mouse Model)
Environmental Conditions
Controlled housing conditions are maintained throughout the study to minimize variability, ensuring strict animal welfare compliance.
Routes of Administration
The route of administration is selected based on the intended use of the test substance and the applicable OECD guideline.
Oral Route: Oral gavage, Dietary administration, Drinking water administration
Dermal Route: Topical application (dermal application)
Inhalation Route: Head/nose-only exposure technique, Whole-body exposure technique
Suitable Product Types
Chronic toxicity studies are essential for determining the safety profile of a wide range of products before clinical use or regulatory approval.
Pharmaceuticals (Drugs)
Pesticides and Agrochemicals
Industrial Chemicals
Environmental Chemicals
Food Additives and Contaminants